Table 5. PCR-confirmed novel and recrudescent infections and time to recrudescence.
1995 | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | Total | |
Total patients treated with MAS3 | 482 | 276 | 29 | 170 | 280 | 98 | 406 | 212 | 252 | 338 | 400 | 183 | 138 | 3264 |
Inconclusive (N) | 0 | 0 | 0 | 0 | 1 | 1 | 4 | 0 | 0 | 2 | 4 | 3 | 0 | 15 |
Missing (N) | 11 | 3 | 0 | 0 | 0 | 2 | 3 | 0 | 1 | 9 | 2 | 0 | 2 | 33 |
Novel infections (N) | 11 | 5 | 0 | 1 | 7 | 13 | 29 | 12 | 13 | 23 | 30 | 25 | 8 | 177 |
Days to novel infection median, [range] | 35 [21–64] | 42 [35–63] | - | 37 | 36 [28–42] | 36.5 [20–49] | 34.5 [14–63] | 42 [21–63] | 43.5 [14–63] | 34 [13–61] | 43 [14–70] | 33 [21–63] | 31.5 [14–50] | 34.0 [13–45] |
Recrudescent infections (N) | 8 | 5 | 0 | 0 | 1 | 7 | 14 | 8 | 9 | 20 | 25 | 7 | 4 | 108 |
Days to recrudescence median, [range] | 21 [14–41] | 21 [16–36] | - | - | 21 | 23 [15–33] | 21 [14–42] | 23.5 [21–42] | 21 [7–28] | 21 [15–42] | 23 [14–42] | 28 [21–42] | 28 [23–34] | 21 [7–42] |